Bioimaging in Neurodegeneration (Contemporary Neuroscience) [Paperback]

Description: Bioimaging is in the forefront of medicine for the diagnosis and helps to predict the progression of AD via mild cognitive treatment of neurodegenerative disease. Conventional magnetic impairment (MCI) studies. resonance imaging (MRI) uses interactive external magnetic fields Novel neuroimaging technologies, such as neuromolecular and resonant frequencies of protons from water molecules. imaging (NMI) with a series of newly developed BRODERICK ® However, newer sequences, such as magnetization-prepared rapid PROBE sensors, directly image neurotransmitters, precursors, acquisition gradient echo (MPRAGE), are able to seek higher and metabolites in vivo, in real time and within seconds, at separate levels of anatomic resolution by allowing more rapid temporal and selective waveform potentials. NMI, which uses an imaging. Magnetic resonance spectroscopy (MRS) images electrochemical basis for detection, enables the differentiation of metabolic changes, enabling underlying pathophysiologic neurodegenerative diseases in patients who present with mesial dysfunction in neurodegeneration to be deciphered. Neuro- versus neocortical temporal lobe epilepsy. In fact, NMI has some 1 chemicals visible with proton H MRS include N-acetyl aspartate remarkable similarities to MRI insofar as there is technological (NAA), creatine/phosphocreatine (Cr), and choline (Cho); NAA dependence on electron and proton transfer, respectively, and is considered to act as an in vivo marker for neuronal loss and/or further dependence is seen in both NMI and MRI on tissue neuronal dysfunction. By extending imaging to the study of composition such as lipids. Prologue: Nano- and Microimaging Surgical Anesthesia in Epilepsy Patients I. Parkinson's Disease Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Parkinson's Disease: Structural vs Functional Changes W. R. Wayne Martin Positron Emission Tomography and Single-Photon Emission Tomography in the Diagnosis of Parkinson's Disease: Differential Diagnosis From Parkinson-Like Degenerative Diseases Paul D. Acton Positron Emission Tomography in Parkinson's Disease: Cerebral Activation Studies and Neurochemical and Receptor Research André R. Troiano and A. Jon Stoessl [123I]-Altropane SPECT: How It Compares to Other Positron Emission Tomography and Single-Photon Emission Tomography Dopamine Transporters in Early Parkinson's Disease Hubert H. Fernandez, Paula D. Ravin, and Dylan P. Wint Positron Emission Tomography and Embryonic Dopamine Cell Transplantation in Parkinson's Disease Yilong Ma, Vijay Dhawan, Curt Freed, Stanley Fahn, and David Eidelberg II. Alzheimer's Disease Neurotoxicity of the Alzheimer's b-Amyloid Peptide: Spectroscopic and Microscopic Studies David R. Howlett Functional Imaging and Psychopathological Consequences of Inflammation in Alzheimer's Dementia Jan Versijpt, Rudi A. Dierckx, and Jakob Korf Neurotoxic Oxidative Metabolite of Serotonin: Possible Role in Alzheimer's Disease Ladislav Volicer, Monika Z. Wrona, W. R. Wayne Matson, and Glenn Dryhurst Predicting Progression of Alzheimer's Disease With Magnetic Resonance Kejal Kantarci and Clifford R. Jack, Jr. Stages of Brain Functional Failure in Alzheimer's Disease: In Vivo Positron Emission Tomography and Postmortem Studies Suggest Potential Initial Reversibility and Later Irreversibility Stanley I. Rapoport III. Epilepsy Neocortical Epilepsy: a-Methyl-l-Tryptophan and Positron EmissionTomography Studies Jun Natsume, Andrea Bernasconi, and Mirko Diksic Pediatric Cortical Dysplasia: Positron Emission Tomography Studies Bharathi Dasan Jagadeesan, Csaba Juhász, Diane C. Chugani, and Harry T. Chugani Bioimaging l-Tryptophan in Human Hippocampus and Neocortex: Subtyping Temporal Lobe Epilepsy Steven V. Pacia and Patricia A. Broderick In Vivo Intrinsic Optical Signal Imaging of Neocortical Epilepsy Sonya Bahar, Minah Suh, Ashesh Mehta, and Theodore H. Schwartz Intraoperative Magnetic Resonance Imaging in the Surgical Treatment of Epilepsy Theodore H. Schwartz Periodic Epileptiform Discharges Associated With Increased Cerebral Blood Flow: Role of Single-Photon Emission Tomography Imaging Imran I. Ali and Noor A. Pirzada Imaging White Matter Signals in Epilepsy Patients: A Unique Sensor Technology Patricia A. Broderick and Steven V. Pacia IV. Leukodystrophy (White Matter) Diseases Overview of the Leukoencephalopathies: An MRI Point of View Edwin H. Kolodny Pyramidal Tract Involvement in Adult Krabbe's Disease: Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy Abnormalities Laura Farina, Alberto Bizzi, and Mario Savoiardo Imaging Leukodystrophies: Focus on Lysosomal, Peroxisomal, and Non-Organelle Pathology Annette O. Nusbaum Advanced Magnetic Resonance Imaging in Leukodystrophies Edwin Y. Wang and Meng Law Childhood Mitochondrial Disorders and Other Inborn Errors of Metabolism Presenting With White Matter Disease Adeline Vanderver and Andrea L. Gropman Mitochondrial Disease: Brain Oxidative Metabolism Studied by 31P, 1H, and 13C Magnetic Resonance Spectroscopy, Functional Magnetic Resonance Imaging, and Positron Emission Tomography Graham J. Kemp Index

Price: 419 AUD

Location: Hillsdale, NSW

End Time: 2025-01-04T21:30:38.000Z

Shipping Cost: 31.15 AUD